标题
The problem of choice: current biologic agents and future prospects in RA
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 9, Issue 3, Pages 154-163
出版商
Springer Nature
发表日期
2013-02-19
DOI
10.1038/nrrheum.2013.8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Biologics for rheumatoid arthritis: an overview of Cochrane reviews
- (2017) Jasvinder A. Singh et al. Sao Paulo Medical Journal
- Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis
- (2014) M. A. Nowell et al. JOURNAL OF IMMUNOLOGY
- A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
- (2012) P Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments
- (2012) Fabien Dépis et al. ARTHRITIS AND RHEUMATISM
- Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation
- (2012) Hideyuki Yoshida et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel small-molecular therapeutics for rheumatoid arthritis
- (2012) Roy Fleischmann CURRENT OPINION IN RHEUMATOLOGY
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
- (2012) Kalle J. Aaltonen et al. PLoS One
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial
- (2011) P. C. Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- The regulation of TNF signalling: what a tangled web we weave
- (2011) John Silke CURRENT OPINION IN IMMUNOLOGY
- CTLA-4-Ig Therapy Diminishes the Frequency but Enhances the Function of Treg Cells in Patients with Rheumatoid Arthritis
- (2011) Crisol Álvarez-Quiroga et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Synovial Tissue Analysis for the Discovery of Diagnostic and Prognostic Biomarkers in Patients with Early Arthritis
- (2011) M. J. H. de HAIR et al. JOURNAL OF RHEUMATOLOGY
- Safety of biologic therapy in rheumatoid arthritis
- (2011) Robert S. Woodrick et al. Nature Reviews Rheumatology
- Synovial Tissue Heterogeneity and Peripheral Blood Biomarkers
- (2011) Serena Bugatti et al. Current Rheumatology Reports
- State-of-the-art: rheumatoid arthritis
- (2010) I. B. McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials
- (2010) M. G. H. van de Sande et al. ANNALS OF THE RHEUMATIC DISEASES
- Management of nonresponse to rituximab in rheumatoid arthritis: Predictors and outcome of re-treatment
- (2010) E. M. Vital et al. ARTHRITIS AND RHEUMATISM
- TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin
- (2010) David J. Mahoney et al. ARTHRITIS AND RHEUMATISM
- Progress and Promise of Genome-Wide Association Studies for Human Complex Trait Genetics
- (2010) B. E. Stranger et al. GENETICS
- CD4+ T Cell Plasticity—Th2 Cells Join the Crowd
- (2010) Jinfang Zhu et al. IMMUNITY
- Epigenetic Instability of Cytokine and Transcription Factor Gene Loci Underlies Plasticity of the T Helper 17 Cell Lineage
- (2010) Ryuta Mukasa et al. IMMUNITY
- Abatacept Limits Breach of Self-Tolerance in a Murine Model of Arthritis via Effects on the Generation of T Follicular Helper Cells
- (2010) A. M. Platt et al. JOURNAL OF IMMUNOLOGY
- Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity
- (2010) R. Lissilaa et al. JOURNAL OF IMMUNOLOGY
- The Functions of Signal Transducers and Activators of Transcriptions 1 and 3 as Cytokine-Inducible Proteins
- (2010) HyeonJoo Cheon et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Tocilizumab for Rheumatoid Arthritis: A Cochrane Systematic Review
- (2010) J. A. SINGH et al. JOURNAL OF RHEUMATOLOGY
- Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects
- (2010) David M. Goldenberg et al. LEUKEMIA & LYMPHOMA
- Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
- (2010) Eli A Stahl et al. NATURE GENETICS
- Effector T cell plasticity: flexibility in the face of changing circumstances
- (2010) Kenneth M Murphy et al. NATURE IMMUNOLOGY
- Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers
- (2010) Thomas Dörner et al. PHARMACOLOGY & THERAPEUTICS
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
- (2010) Mona Gandhi et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Predictors for remission in rheumatoid arthritis patients: A systematic review
- (2010) Wanruchada Katchamart et al. ARTHRITIS CARE & RESEARCH
- Mechanisms of inflammation in gout
- (2010) Nathalie Busso et al. ARTHRITIS RESEARCH & THERAPY
- Cytokine/Jak/Stat Signaling Mediates Regeneration and Homeostasis in the Drosophila Midgut
- (2009) Huaqi Jiang et al. CELL
- Ocrelizumab: a step forward in the evolution of B-cell therapy
- (2009) Fariha Kausar et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4+ T Cells
- (2009) Gang Wei et al. IMMUNITY
- Plasticity of CD4+ T Cell Lineage Differentiation
- (2009) Liang Zhou et al. IMMUNITY
- Late Developmental Plasticity in the T Helper 17 Lineage
- (2009) Yun Kyung Lee et al. IMMUNITY
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population
- (2009) Hyeok-Jae Ko et al. JOURNAL OF AUTOIMMUNITY
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- Rheumatoid arthritis
- (2009) Lars Klareskog et al. LANCET
- Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
- (2009) Jean-Michel Dayer et al. RHEUMATOLOGY
- Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORγt in γδ T cells
- (2009) Ferry Cornelissen et al. ARTHRITIS RESEARCH & THERAPY
- Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study
- (2008) M H Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Cytokine Signaling Modules in Inflammatory Responses
- (2008) John J. O'Shea et al. IMMUNITY
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future
- (2008) J. D. Isaacs RHEUMATOLOGY
- IMMUNOLOGY: Regulating Suppression
- (2008) E. M. Shevach SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now